Greg Connelly is an Associate Director in Formulation at Vertex Pharmaceuticals in Boston, MA. He is the Drug Product Continuous Manufacturing (CM) Lead and he has been a key driver of the Vertex CM initiative from its inception. He has guided the development of several Vertex products as they transitioned from batch to continuous processes. His team works to increase fundamental understanding of the various unit operations which comprise Vertex’s Drug Product CM rig, and they manage all design, testing and qualification of process equipment on the system. Greg holds a BS in physics & mathematics from Loyola University and a PhD in biophysics from the University of Pennsylvania. Over the past 16 years, his work in the pharmaceutical industry has spanned the range from early-stage research to commercial product development.